Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

The benefits of using fractional doses of COVID-19 vaccines

The benefits of using fractional doses of COVID-19 vaccines

First dose SARS-CoV-2 vaccination coverage among younger children in America

First dose SARS-CoV-2 vaccination coverage among younger children in America

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Study explores coronavirus surveillance in bats from Argentina

Study explores coronavirus surveillance in bats from Argentina

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

Assessing the potential of IFNa subtypes in suppressing SARS-CoV-2

Assessing the potential of IFNa subtypes in suppressing SARS-CoV-2

A model for predicting the evolution of the Omicron wave

A model for predicting the evolution of the Omicron wave

Scientists find no connection between pandemic chilblains and SARS-CoV-2 infection

Scientists find no connection between pandemic chilblains and SARS-CoV-2 infection

Using Hla-A*32 allele as a prognostic indicator of COVID-19 severity

Using Hla-A*32 allele as a prognostic indicator of COVID-19 severity

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Dual therapeutic potential of zapnometinib against COVID-19

Dual therapeutic potential of zapnometinib against COVID-19

Similarities between SARS-CoV-2 and human retroelements explored

Similarities between SARS-CoV-2 and human retroelements explored

Durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection

Durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection

Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

The prevalence of SARS-CoV-2 in environment and animal samples from the Huanan seafood market

The prevalence of SARS-CoV-2 in environment and animal samples from the Huanan seafood market

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.